On 2nd October, 2023, MP Shah Hospital became the first hospital in Africa to join the CaReMe Global Alliance, in a milestone collaboration to improve outcomes for patients with cardiovascular, renal, and metabolic (CVRM) diseases in Kenya, including conditions like diabetes, heart failure and chronic kidney disease.
Spearheaded by global pharmaceutical company AstraZeneca, the CaReMe
Global Alliance, is dedicated to transforming CVRM care, from an approach that targets each condition individually, to one that treats all three comorbidities as one.
This approach is already demonstrating its ability to improve clinical outcomes, lower costs, and optimize resource utilization in partner hospitals globally. As a member of the Alliance, MP Shah Hospital takes pride in being the pioneer in Africa, to adopt this streamlined model of CVRM care, a more sustainable healthcare system.
This new collaboration aims to address this rising burden in Kenya, aiming to engage 400 patients in the iCaReMe registry in the first year. Key objectives include integrating cardiology, diabetic, and renal clinics, managing patients holistically, and evaluating outcomes based on the CaReMe Model approach.
Also Read: LOOP DFS, Amani Project Team Up to Cultivate Cycling Culture
“AstraZeneca is proud to support the integrated, patient-centric care approach championed by CaReMe, which has been shown to have a significant impact on the overall quality of health services and the quality of life of patients living with conditions like diabetes, heart, and kidney diseases. Moreover, it is a model that supports health system resilience and sustainability in Kenya by reducing costs and streamlining care, helping to pave the way for a greener, healthier tomorrow, ” said Khomotso Mashilane, Medical Director for AstraZeneca in African Cluster during the event.
In addition, Dr. Hussein Bagha, Internal Medicine HOD also spoke saying that MP Shah Hospital is thrilled to become the first in Africa to join the Global CaReMe Alliance. This as the integrated model of care for cardiovascular, renal, and metabolic diseases is proven to benefit patient outcomes and improve their overall experience, paving the way for better treatment across Kenya of these increasingly common diseases.
